First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) — Defensive Interval Ratio
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Defensive Interval Ratio of 419 days as of March 2026. Defensive assets of $37.99 Million (cash $-, short-term investments $37.99 Million, receivables $-) cover 419 days of daily cash needs of $90.72K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Defensive Interval Ratio (2023–2024)
This chart shows how First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's Defensive Interval Ratio has evolved across 2 annual periods from 2023 to 2024. As of March 2026, the ratio stands at 419 days, meaning defensive assets of $37.99 Million can fund 419 days of operations without new revenue. For the complete balance sheet picture, see First Tracks Biotherapeutics, Inc. Ordin total assets.
Annual Defensive Interval Ratio for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
The table below presents the year-by-year Defensive Interval Ratio for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued from 2023 to 2024, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See First Tracks Biotherapeutics, Inc. Ordin working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2646 days | $262.29 Million | $99.13K/day | $- | $262.29 Million | ▼ -4463 days |
| 2023 | 7109 days | $354.94 Million | $49.93K/day | $- | $354.94 Million | — |